HOUSE 5027118th CongressReferred to the Subcommittee on Health.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
- Last Action
- 12/17/2024
Actions
- 2024-12-17Referred to the Subcommittee on Health.
- 2023-07-28Referred to the Subcommittee on Health.
- 2023-07-27Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-07-27Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-07-27Introduced in House
- 2023-07-27Introduced in House
Cosponsors (13)
- Terri Sewell (D-AL)
- Susan Wild (D-PA)
- JERROLD NADLER (D-NY)
- Yadira Caraveo (D-CO)
- Yvette Clarke (D-NY)
- Vern Buchanan (R-FL)
- Michelle Steel (R-CA)
- Eleanor Norton (D-DC)
- Steve Cohen (D-TN)
- Frank Mrvan (D-IN)
- Raja Krishnamoorthi (D-IL)
- Alma Adams (D-NC)
- Joe Neguse (D-CO)
Subjects
- Advanced technology and technological innovations
- Congressional oversight
- Digestive and metabolic diseases
- Drug therapy
- Government studies and investigations
- Health care coverage and access
- Health personnel
- Health promotion and preventive care
- Health technology, devices, supplies
- Higher education
- Medical research
- Medical tests and diagnostic methods
- Medicare
- National and community service
- Prescription drugs
- Student aid and college costs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.